C17H14F3N3O2S
381.4 g/mol
Pharmaceutical IntermediateWarning
4-Desmethyl-2-methyl Celecoxib
CAS170569-99-0
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a fluorinated pyrazole sulfonamide derivative that serves as an impurity reference standard for the pharmaceutical compound celecoxib. It is characterized by a structural modification involving a methyl group rearrangement on the phenyl ring.
Pharmaceutical impurity reference standardQuality control in pharmaceutical manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 170569-99-0
Related Compounds
SimilarStructure SimilarSimilarity 0.77
2,5-Dimethylcelecoxib
CAS457639-26-8
pharmaceutical raw material
ReferenceSame Category
4-Chloro-3-methoxypyridine-2-carboxylic acid
CAS170621-86-0
pharmaceutical intermediate
ReferenceSame Category
Diphenylphosphinic acid
CAS1707-03-5
pharmaceutical intermediate
ReferenceSame Category
1,3-Adamantanediol
CAS17071-62-4
pharmaceutical intermediate
ReferenceSame Category
3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester acetate
CAS170749-59-4
pharmaceutical intermediate
Referencesame scaffold
Celecoxib
CAS169590-42-5
pharmaceutical raw material
Referencesame scaffold
CHEMBL29923
CAS170570-01-1
pharmaceutical raw material
Referencesame scaffold
Mavacoxib
CAS170569-88-7
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
4-[5-(2-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
InChIKey
QGNNQDAQBISHQG-UHFFFAOYSA-N
SMILES
CC1=CC=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
Synonyms (9)
- Celecoxib Impurity 8
- Celecoxib Impurity D